A detailed history of Franklin Street Advisors Inc transactions in Danaher Corp stock. As of the latest transaction made, Franklin Street Advisors Inc holds 75,562 shares of DHR stock, worth $17.3 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
75,562
Previous 74,867 0.93%
Holding current value
$17.3 Million
Previous $18.7 Million 12.31%
% of portfolio
1.42%
Previous 1.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$239.25 - $280.76 $166,278 - $195,128
695 Added 0.93%
75,562 $21 Million
Q2 2024

Jul 18, 2024

BUY
$235.51 - $267.98 $2.17 Million - $2.46 Million
9,193 Added 14.0%
74,867 $18.7 Million
Q1 2024

Apr 15, 2024

BUY
$224.58 - $256.19 $58,839 - $67,121
262 Added 0.4%
65,674 $16.4 Million
Q4 2023

Jan 18, 2024

SELL
$185.1 - $233.13 $114,762 - $144,540
-620 Reduced 0.94%
65,412 $15.1 Million
Q3 2023

Oct 10, 2023

SELL
$233.08 - $265.59 $442,385 - $504,089
-1,898 Reduced 2.79%
66,032 $16.4 Million
Q2 2023

Jul 13, 2023

SELL
$224.99 - $256.14 $477,878 - $544,041
-2,124 Reduced 3.03%
67,930 $16.3 Million
Q1 2023

Apr 12, 2023

SELL
$239.75 - $277.0 $2.4 Million - $2.77 Million
-10,006 Reduced 12.5%
70,054 $17.7 Million
Q4 2022

Feb 07, 2023

SELL
$241.42 - $282.29 $1.58 Million - $1.85 Million
-6,563 Reduced 7.58%
80,060 $21.3 Million
Q3 2022

Oct 11, 2022

BUY
$247.06 - $1507.4 $33,847 - $206,513
137 Added 0.16%
86,623 $22.4 Million
Q2 2022

Jul 13, 2022

SELL
$237.11 - $299.66 $216,481 - $273,589
-913 Reduced 1.04%
86,486 $21.9 Million
Q1 2022

Apr 18, 2022

BUY
$257.27 - $315.76 $81,040 - $99,464
315 Added 0.36%
87,399 $25.6 Million
Q4 2021

Jan 26, 2022

SELL
$292.08 - $329.01 $522,531 - $588,598
-1,789 Reduced 2.01%
87,084 $28.7 Million
Q3 2021

Oct 22, 2021

SELL
$272.21 - $332.43 $1.53 Million - $1.86 Million
-5,609 Reduced 5.94%
88,873 $27.1 Million
Q2 2021

Aug 05, 2021

SELL
$225.08 - $271.69 $1.34 Million - $1.62 Million
-5,949 Reduced 5.92%
94,482 $25.4 Million
Q1 2021

May 04, 2021

SELL
$212.38 - $245.9 $1.07 Million - $1.24 Million
-5,050 Reduced 4.79%
100,431 $22.6 Million
Q4 2020

Feb 01, 2021

SELL
$212.5 - $245.46 $1.36 Million - $1.57 Million
-6,393 Reduced 5.71%
105,481 $23.4 Million
Q3 2020

Oct 21, 2020

SELL
$177.16 - $215.33 $250,681 - $304,691
-1,415 Reduced 1.25%
111,874 $24.1 Million
Q2 2020

Aug 06, 2020

SELL
$128.7 - $176.83 $306,949 - $421,739
-2,385 Reduced 2.06%
113,289 $20 Million
Q1 2020

Apr 16, 2020

SELL
$121.39 - $169.05 $1.59 Million - $2.21 Million
-13,092 Reduced 10.17%
115,674 $16 Million
Q4 2019

Feb 14, 2020

BUY
$133.47 - $153.48 $33,901 - $38,983
254 Added 0.2%
128,766 $19.8 Million
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $53,483 - $57,855
395 Added 0.31%
128,512 $18.6 Million
Q2 2019

Aug 07, 2019

BUY
$124.88 - $143.73 $149,106 - $171,613
1,194 Added 0.94%
128,117 $18.3 Million
Q1 2019

May 14, 2019

SELL
$97.62 - $132.29 $2.51 Million - $3.4 Million
-25,727 Reduced 16.85%
126,923 $16.8 Million
Q4 2018

Feb 14, 2019

SELL
$94.85 - $109.54 $213,886 - $247,012
-2,255 Reduced 1.46%
152,650 $15.7 Million
Q3 2018

Oct 05, 2018

BUY
$98.13 - $108.9 $3.5 Million - $3.88 Million
35,649 Added 29.89%
154,905 $16.8 Million
Q2 2018

Jul 16, 2018

BUY
$96.1 - $103.24 $2.11 Million - $2.26 Million
21,936 Added 22.54%
119,256 $11.8 Million
Q1 2018

Apr 11, 2018

SELL
$92.16 - $103.8 $1.27 Million - $1.43 Million
-13,790 Reduced 12.41%
97,320 $9.53 Million
Q4 2017

Jan 10, 2018

SELL
$85.26 - $94.62 $113,822 - $126,317
-1,335 Reduced 1.19%
111,110 $10.3 Million
Q3 2017

Oct 11, 2017

BUY
$79.29 - $88.45 $8.92 Million - $9.95 Million
112,445
112,445 $9.65 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Franklin Street Advisors Inc Portfolio

Follow Franklin Street Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.